2586
H. Mao et al.
PAPER
1H NMR (400 Hz, DMSO-d6): d = 6.68–6.73 (m, 1 H), 6.91–6.98
(m, 2 H), 7.06–7.10 (m, 1 H), 7.43–7.51 (m, 4 H), 7.76 (d, J = 8.0
Hz, 2 H), 7.90 (d, J = 8.0 Hz, 2 H), 8.22 (d, J = 8.0 Hz, 2 H), 9.33
(d, J = 8.0 Hz, 1 H), 11.00 (s, 1 H).
13C NMR (100 Hz, DMSO-d6): d = 50.2, 112.2, 115.5, 119.0, 119.4,
122.0, 124.0, 124.7, 126.4, 128.1, 128.7, 129.0, 131.8, 134.7, 137.0,
147.0, 151.1, 166.5.
IR (KBr): 3418, 3269, 3060, 1657, 1495, 743 cm–1.
1H NMR (400 Hz, CDCl3): d = 2.07 (s, 3 H), 6.30 (s, 1 H), 6.70 (d,
J = 8.0 Hz, 1 H), 7.01 (t, J = 8.0 Hz, 1 H), 7.19–7.31 (m, 6 H), 7.40–
7.49 (m, 4 H), 7.59 (d, J = 8.0 Hz, 2 H), 8.25 (s, 1 H).
13C NMR (100 Hz, CDCl3): d = 22.9, 49.3, 111.8, 112.6, 119.2,
120.9, 121.9, 126.9, 127.1, 127.2, 128.3, 128.6, 129.0, 129.2, 132.9,
136.3, 136.8, 142.9, 169.2.
MS (EI, 70 eV): m/z (%) = 207 (100) [M + H – NO2 – PhCONH2]+,
178 (16.5), 129 (26.4), 117 (99.2), 91 (96.3), 77 (61.1).
MS (EI, 70 eV): m/z (%) = 220 (100) [M – Ph – COCH3]+, 205
(99.8), 177 (95.3), 145 (98.3), 105 (66.8), 57 (99.7).
Anal. Calcd for C22H17N3O3: C, 71.15; H, 4.61; N, 11.31. Found: C,
70.99; H, 4.46; N, 11.15.
Anal. Calcd for C23H20N2O: C, 81.15; H, 5.92; N, 8.23. Found: C,
80.96; H, 6.07; N, 8.32.
N-[(4-Methoxyphenyl)(2-methyl-1H-indol-3-yl)methyl]acet-
amide (3e)
White powder; mp 160–163 °C.
IR (KBr): 3405, 3268, 3058, 1630, 1544, 696 cm–1.
1H NMR (400 Hz, DMSO-d6): d = 1.92 (s, 3 H), 2.34 (s, 3 H), 3.35
(s, 3 H), 6.33 (d, J = 8.0 Hz, 1 H), 6.85–6.93 (m, 2 H), 7.18–7.37
(m, 6 H), 8.63 (s, 1 H), 10.80 (s, 1 H).
13C NMR (100 Hz, DMSO-d6): d = 21.8, 23.1, 40.0, 49.6, 111.7,
116.5, 118.8, 123.3, 124.0, 126.6, 127.1, 127.5, 128.5, 135.4, 143.6,
168.7.
N-[(1-Benzyl-1H-indol-3-yl)(4-methoxyphenyl)methyl]acet-
amide (3i)
White powder; mp 174–176 °C.
IR (KBr): 3327, 3131, 1693, 1543, 753 cm–1.
1H NMR (400 Hz, DMSO-d6): d = 1.87 (s, 3 H), 3.72 (s, 3 H), 5.34
(s, 2 H), 6.29 (d, J = 8.0 Hz, 1 H), 7.39–6.87 (m, 14 H), 8.62 (d,
J = 8.0 Hz, 1 H).
13C NMR (100 Hz, DMSO-d6): d = 23.1, 48.9, 49.4, 55.5, 110.7,
114.0, 117.3, 119.4, 119.7, 122.0, 127.0, 127.4, 127.6, 127.8, 128.7,
129.0, 135.2, 136.9, 138.8, 158.5, 168.6.
MS (EI, 70 eV): m/z (%) = 218 (30.1) [M – H – OCH3
–
MS (EI, 70 eV): m/z (%) = 327 (3.1) [M + H – NHCOCH3]+, 221
(98.3), 205 (100) [M + H – PhCH2 – OCH3 – CH3CONH]+, 177
(66.4), 145 (75.9), 119 (99.1), 91 (99.7), 64 (99.5).
NHCOCH3]+, 207 (78.9), 117 (96.3), 91 (100) [PhCH2]+, 77 (22.6).
Anal. Calcd for C19H20N2O2: C, 74.00; H, 6.54; N, 9.08. Found: C,
74.13; H, 6.40; N, 9.17.
Anal. Calcd for C25H24N2O2: C, 78.10; H, 6.29; N, 7.29. Found: C,
78.32; H, 6.16; N, 7.17.
N-[(2-Methyl-1H-indol-3-yl)(phenyl)methyl]acetamide (3f)
White powder; mp 160–163 °C.
IR (KBr): 3382, 3324, 3057, 1639, 1536, 744 cm–1.
N-[(1-Benzyl-1H-indol-3-yl)(phenyl)methyl]acetamide (3j)
White powder; mp 181–184 °C.
1H NMR (400 Hz, CDCl3): d = 2.05 (s, 3 H), 2.37 (s, 3 H), 6.25 (d,
J = 8.0 Hz, 1 H), 6.54 (d, J = 8.0 Hz, 1 H), 6.92–6.96 (m, 1 H), 7.09
(d, J = 8.0 Hz, 2 H), 7.21–7.30 (m, 5 H), 8.23 (s, 1 H).
13C NMR (100 Hz, CDCl3): d = 12.0, 23.4, 49.2, 110.7, 111.5,
118.5, 119.6, 121.3, 126.6, 126.9, 128.4, 129.1, 133.3, 135.5, 141.2,
169.5.
MS (EI, 70 eV): m/z (%) = 279 (30.6) [M + H]+, 278 (100) [M]+,
235 (40.5), 220 (95.2), 204 (31.7), 148 (99.3), 132 (45.0), 106
(94.3).
IR (KBr): 3300, 3059, 1641, 1538, 741 cm–1.
1H NMR (400 Hz, CDCl3): d = 2.05 (s, 3 H), 5.23 (s, 2 H), 6.10 (d,
J = 8.0 Hz, 1 H), 6.54 (d, J = 8.0 Hz, 1 H), 6.74 (s, 1 H), 7.08 (t,
J = 6.8 Hz, 3 H), 7.19 (s, 1 H), 7.25–7.29 (m, 5 H), 7.32–7.40 (m,
4 H), 7.48 (d, J = 8.0 Hz, 1 H).
13C NMR (100 Hz, CDCl3): d = 23.4, 50.1, 50.3, 110.1, 116.5,
119.6, 119.8, 122.4, 126.7, 127.0, 127.3, 127.55, 127.59, 127.7,
128.5, 128.8, 137.1, 137.3, 141.3, 169.2.
MS (EI, 70 eV): m/z (%) = 341 (100) [M + 2H – CH3]+, 298 (51.3),
Anal. Calcd for C18H18N2O: C, 77.67; H, 6.52; N, 10.06. Found: C,
77.48; H, 6.64; N, 9.89.
204 (73.1), 117 (34.6), 104 (70.9), 91 (18.3).
Anal. Calcd for C24H22N2O: C, 81.33; H, 6.26; N, 7.90. Found: C,
81.54; H, 6.32; N, 7.79.
N-[(4-Methoxyphenyl)(2-phenyl-1H-indol-3-yl)methyl]acet-
amide (3g)
White powder; mp 200–202 °C.
IR (KBr): 3421, 3270, 1662, 1510, 747 cm–1.
1H NMR (400 Hz, CDCl3): d = 2.03 (s, 3 H), 3.77 (s, 3 H), 6.30 (d,
J = 8.0 Hz, 1 H), 6.65 (d, J = 8.0 Hz, 1 H), 6.80 (d, J = 8.0 Hz, 2 H),
7.02 (t, J = 8.0 Hz, 1 H), 7.18–7.26 (m, 3 H), 7.38–7.46 (m, 4 H),
7.57 (d, J = 8.0 Hz, 2 H), 8.30 (s, 1 H).
13C NMR (100 Hz, CDCl3): d = 23.4, 49.3, 55.3, 111.4, 112.0,
113.8, 119.7, 120.1, 122.5, 126.9, 128.0, 128.48, 128.53, 129.1,
132.2, 133.6, 136.2, 136.5, 158.5, 169.4.
N-[(5-Bromo-1H-indol-3-yl)(phenyl)methyl]benzamide (3k)
White powder; mp 179–181 °C.
IR (KBr): 3310, 3127, 1656, 1510, 826 cm–1.
1H NMR (400 Hz, CDCl3): d = 6.64 (d, J = 8.0 Hz, 1 H), 6.73 (d,
J = 7.6 Hz, 1 H), 6.81 (s, 1 H), 7.21–7.52 (m, 8 H), 7.62 (s, 1 H),
7.79–7.84 (m, 3 H), 8.36 (s, 1 H).
13C NMR (100 Hz, CDCl3): d = 50.8, 112.9, 113.3, 116.9, 121.9,
124.9, 125.5, 125.9, 127.0, 127.1, 127.2, 127.6, 128.7, 131.7, 134.2,
135.4, 140.8, 166.7.
MS (EI, 70 eV): m/z (%) = 220 (67.4), 205 (100) [M – Br – Ph-
MS (EI, 70 eV): m/z (%) = 193 (99.5) [2-phenyl-3-indolyl]+, 163
(68.8), 115 (26.4), 92 (98.9), 77 (29.7), 71 (69.3).
CONH]+, 177 (30.7), 145 (32.0), 115 (15.8), 105 (21.1), 81 (21.1).
Anal. Calcd for C22H17BrN2O: C, 65.20; H, 4.23; N, 6.91. Found: C,
65.53; H, 4.21; N, 6.81.
Anal. Calcd for C24H22N2O2: C, 77.81; H, 5.99; N, 7.56. Found: C,
77.65; H, 6.12; N, 7.38.
N-[(5-Bromo-1H-indol-3-yl)(phenyl)methyl]acetamide (3l)
White powder; mp 140–143 °C.
IR (KBr): 3298, 3122, 1668, 1517, 1401, 750 cm–1.
N-[Phenyl(2-phenyl-1H-indol-3-yl)methyl]acetamide (3h)
White powder; mp 250 °C (dec.).
Synthesis 2008, No. 16, 2582–2588 © Thieme Stuttgart · New York